These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3057674)

  • 21. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study.
    Bjermer L; Lemiere C; Maspero J; Weiss S; Zangrilli J; Germinaro M
    Chest; 2016 Oct; 150(4):789-798. PubMed ID: 27056586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.
    La Grutta S; Nicolini G; Capristo C; Bellodi SC; Rossi GA
    Monaldi Arch Chest Dis; 2007 Mar; 67(1):30-8. PubMed ID: 17564282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study.
    O'Byrne PM; D'Urzo T; Beck E; Fležar M; Gahlemann M; Hart L; Blahova Z; Toorawa R; Beeh KM
    Respir Res; 2015 Aug; 16(1):97. PubMed ID: 26283085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
    Wasserman SI; Gross GN; Schoenwetter WF; Munk ZM; Kral KM; Schaberg A; Kellerman DJ
    J Asthma; 1996; 33(4):265-74. PubMed ID: 8707781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ferguson GT; FitzGerald JM; Bleecker ER; Laviolette M; Bernstein D; LaForce C; Mansfield L; Barker P; Wu Y; Jison M; Goldman M;
    Lancet Respir Med; 2017 Jul; 5(7):568-576. PubMed ID: 28545978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of the endothelin-1 receptor antagonist, bosentan, on patients with poorly controlled asthma: a 17-week, double-blind, placebo-controlled crossover pilot study.
    Coyle TB; Metersky ML
    J Asthma; 2013 May; 50(4):433-7. PubMed ID: 23363065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of naloxone on circadian rhythms in lung function.
    Al-Damluji S; Thompson PJ; Citron KM; Turner-Warwick M
    Thorax; 1983 Dec; 38(12):914-8. PubMed ID: 6364441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled prazosin in asthma.
    Barnes PJ; Ind PW; Dollery CT
    Thorax; 1981 May; 36(5):378-81. PubMed ID: 6118964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
    Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roflumilast for asthma: Efficacy findings in non-placebo-controlled comparator and dosing studies.
    Bateman ED; Bousquet J; Aubier M; Bredenbröker D; O'Byrne PM
    Pulm Pharmacol Ther; 2015 Dec; 35 Suppl():S11-9. PubMed ID: 26456372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
    Kerwin EM; Oppenheimer JJ; LaForce C; Parasuraman B; Miller CJ; O'Dowd L; Goldman M
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitonin nasal spray in patients with chronic asthma: a double-blind crossover study vs placebo.
    Dal Negro R; Turco P; Pomari C; Trevisan F
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):144-6. PubMed ID: 2071263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA; Schreurs AJ; Mol SJ; Mulder PG
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma.
    Chan R; Sousa AR; Mallett S; Hynds P; Homayoun-Valiani F; Tabberer M; Mehta R
    Pulm Pharmacol Ther; 2016 Dec; 41():19-24. PubMed ID: 27599598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acupuncture for bronchial asthma? A double-blind crossover study.
    Tandon MK; Soh PF; Wood AT
    Med J Aust; 1991 Mar; 154(6):409-12. PubMed ID: 2000055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma: Effects Across a Broad Range of Eosinophil Counts.
    Corren J; Weinstein S; Janka L; Zangrilli J; Garin M
    Chest; 2016 Oct; 150(4):799-810. PubMed ID: 27018175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled trial of oral fenoterol in the treatment of childhood asthma.
    Foresi A; Corbo GM; Del Vita M; Agabiti N; Mugnano A
    Ann Allergy; 1989 Jul; 63(1):76-80. PubMed ID: 2662837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.